BioSpace News Archive

Kodiak Sciences Inc. announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024, at 7:30 a.m. Pacific Time.

Edesa Biotech, Inc. announced that company management plans to participate in the 2024 Dermatology Summit on January 7, 2024 as well as in one-on-one meetings alongside the J.P. Morgan 42nd Annual Healthcare Conference from January 8-11, 2024 in San Fransico, California.

PolyPid Ltd. announced that it has entered into a securities purchase agreement for a private placement financing for $16.2 million in gross proceeds priced at the 5-day volume weighted average price as of January 2, 2024 of $4.81 per share.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to one new employee.

DiscGenics, Inc. announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics is presenting at Biotech Showcase 2024.

Mettler-Toledo International Inc. announced that sales and Adjusted EPS for the fourth quarter of 2023 will be below its previously-issued guidance due to unexpected shipping delays with a new external European logistics service provider, which the Company expects to largely recover in the first quarter of 2024.

Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, announced that it has filed the final module in the Pre-Market Approval application with the U.S. Food and Drug Administration for its investigational P-15 Peptide Enhanced Bone Graft.

VolitionRx Limited, a multi-national epigenetics company, has issued a Business Review of 2023, outlining its key highlights from the past year.

The Danish, pharmaceutical company ALK, announced it has successfully completed its acquisition of the business assets of AllerQuest, a U.S.-based company dedicated to manufacturing PRE-PEN® Skin Antigen Test.

Immunexpress, Pty Ltd. announced today the clearance of EDTA blood compatible cartridges by the U.S. Food and Drug Administration (FDA) for use with SeptiCyte RAPID®.